SavedAdd your journal

Journals / Bakırköy Tıp Dergisi / 2015 / Cilt: 11 - Sayı: 3

Laboratory findings of 563 women with telogen effluvium

Telogen Effluviumlu 563 Kadın Hastada Laboratuvar Bulguları

Atıl AVCI
Deniz AVCI
Kemal ÖZYURT
Pages
120–123
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Since the reasons can differ in TE etiology, in our opinion, biochemical tests, complete blood count and hormonal tests must be done in all TE patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:objective: Telogen effluvium (TE) type hair loss is a condition that is commonly seen in dermatology clinics and this disease has multiple etiologic reasons.
📊
Key Findings & Data:We had done this research at TE type patients to determine serum ferritin, vit B12, folic acid , and thyroid function tests.
💡
Conclusion & Impact:Conclusion: Since the reasons can differ in TE etiology, in our opinion, biochemical tests, complete blood count and hormonal tests must be done in all TE patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

objective: Telogen effluvium (TE) type hair loss is a condition that is commonly seen in dermatology clinics and this disease has multiple etiologic reasons. We had done this research at TE type patients to determine serum ferritin, vit B12, folic acid , and thyroid function tests. Material and Methods: In this research, 563 female patients who admitted to Education and Research Hospital’s dermatology outpatient clinics with TE is studied retrospectively. The tests were performed in SPSS 16.0 program to investigate the frequency of the laboratory tests abnormalities. Results: Serum ferritin levels were low in 174 patients (30.91%), serum iron levels were low in 77 patients (13.68%), hematocrit levels were low in 54 patients (9.59%), vitamin B12 levels were low in 17 patients (3.02%), folic acid levels were low in 51 patients (9.06%), serum T4 levels were low in 3 patients (0.53%) and TSH levels were low in 8 patients (1.15%) due to reference ranges. Conclusion: Since the reasons can differ in TE etiology, in our opinion, biochemical tests, complete blood count and hormonal tests must be done in all TE patients.

Özet

Amaç: Telogen effluvium (TE) tipi saç dökülmesi dermatoloji polikliniklerinde oldukça sık karşılaşılan ve bir çok etiyolojik nedeni olabilen bir durumdur. TE ile başvuran hastalarda serum ferritin, vitB12, folik asit ve tiroid fonksiyon testleri bozukluğunun sıklığını saptamak için bu çalışmayı yaptık. Gereç ve Yöntem: Çalışmada, 2008-2013 yılları arasında Eğitim ve Araştırma Hastanemize başvuran telogen effluvium tanısı almış 563 kadın hasta retrospektif olarak değerlendirildi. SPSS-16.0 programı ile bu laboratuvar testleri bozukluğunun görülme sıklığını incelendi. Bulgular: Serum ferritin düzeyleri hastaların 174’ünde (%30.91), serum demir düzeyi 77’sinde (%13.68), hematokrit düzeyi 54’ünde (%9.59) vitamin B12 düzeyleri 17’sinde (%3.02), folik asit düzeyleri 51’inde (%9.06) serum T4 düzeyi 3’ünde (%0.53)ve TSH 8’inde (%1.15) referans aralığına göre düşük bulundu. Sonuç: TE tanısı konulan her hastalarda etiyolojik sebepler çeşitli olabileceğinden biyokimyasal testler, tam kan sayımı ve hormonal testler mutlaka yapılması gerektiği düşüncesindeyiz

🔖

Cite This Article

AVCI, A., AVCI, D., ÖZYURT, K. (2015). Laboratory findings of 563 women with telogen effluvium. Bakırköy Tıp Dergisi, Cilt: 11 - Sayı: 3, 120–123. https://ajindex.com/articles/128803

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002; 33: 457-463
  2. Tyler I, Wiseman MC, Crawford RI, Birmingham CL. Cutaneous manifestations of eating disorders. J Cutan Med Surg 2002; 6: 345- 353
  3. Shrivastava SB. Diffuse hair loss in an adult female: Approach to diagnosis and management. Indian J Dermatol Venereol Leprol 2009; 75: 20-28
  4. Saitoh M, Uzuka M, Sakamoto M. Human hair cycle. J Invest Dermatol 1970; 54: 65-81
  5. Rushton DH, Ramsay ID. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in woman. Clin Endocrinol 1992; 36: 421-427
  6. Güler Özden M, Öztaş MO, Gülekon A, et al. Kadın olgularda yaygın saç kaybı ve eşlik eden bulgular. OMÜ Tıp Dergisi 2008; 25: 50-56
  7. Rushton DH, Norris MJ, Dover R, et al. Causes of hair loss and the developments in hair rejuvenation. Int J of Cosmet Sci 2002; 24: 17-23
  8. Deloche C, Bastien P, Chadoutaud S, et al. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 2007; 17: 507-512
  9. Sinclair RD. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002; 147: 982-984
  10. Bregy A, Trueb RM. No association between serum ferritin levels > 10 microgram/l and hair loss activity in women. Dermatology 2008; 217: 1-6
  11. De Villez R, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female: treatment wiith 2% minoxidil solution. Arch Dermatol 1994; 130: 303-307
  12. Vexian P, Chaspoux C, Boudon P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12 month randomized trial. Br J Dermatol 2002; 146: 992-999
  13. Shapiro J. Safety of topical minoxidil: A one year prospective, observational study. J Cutan Med Surg 2003; 7: 322-329
  14. Diamanti-Kandarakis E. Current aspect of antiandrogens therapy in women. Current Pharmaceutical Design 1999; 5: 707-723
  15. Adamopoulos DA, Karamertzanis M, Nickopoulou S, Gregoriou A. Beneficial effect of spironolactone on androgenetic alopecia. Clin Endocrinol (Oxf) 1997; 47: 759-760
  16. Rushton DH. Quantitative assessment of spironolactone treatment in women with diffuse androgen dependent alopecia. J Soc Cosmet Chem 1991; 42: 317.